CBD Health

Before the hype train with mainstream icons like Kim Kardashian on board, CBD was long an obscure cannabinoid that only a handful of scientists believed in. In fact, its long and bumpy road stretches back to ancient times.

Many sources cite Sheng Neng, an ancient Chinese emperor, as the first known cannabis user. A document from the year 2737 BC. BC shows how he used cannabis-infused tea as a remedy for malaria, rheumatism and others.

In 1839, William O’Shaugnessy, an Irish medical researcher, conducted the first study that provided insight into the therapeutic potential of cannabis and sparked the interest of the scientific community.

During the last decade of the 19th century, Queen Victoria apparently relied on cannabis to relieve her menstrual cramps, according to the records of her private doctor.

Evidence of CBD’s rocky relationship with the law is the fact that it was discovered by Roger Adams in 1940 just 3 years after cannabis was illegalized in 1937. As a reference, THC was not isolated until 1964, largely attributed to Roger Adams’ discovery.

In 1946, the first CBD-specific study by Dr. Walter Loewe carried out on laboratory animals.

In the 1970s, things started looking for CBD legally.

In 1973, Oregon became the first state to legalize medical cannabis. In 1978, the medicinal potential of cannabis was officially recognized by the Controlled Substances Therapeutic Research Act.

This, of course, opened the door to studies in particular on cannabis and CBD.

In 1980, Dr. Mechoulam conducted a study that shed light on the anti-seizure properties of CBD. After several years and studies of CBD as a cure for epilepsy, we are entering the pivotal year 2018 when the FDA approved the first CBD drug, EPIDIOLEX, for the treatment of epilepsy. This victory cannot be celebrated without mentioning the famous case of Charlotte Figi, a young Colorado girl plagued by 300 epileptic seizures per week, reduced to 2-3 per month with CBD.

Now, CBD seems to have finally escaped the stigma of its parents’ illegal past. People from all walks of life and status are trumpeting its power, including many famous UFC fighters like Nate Diaz, which is clear evidence not only of the cannabinoid’s legitimacy and effectiveness, but also of its long overdue mainstream acceptance.

“Better late than never” was seldom more appropriate.

Cannabis licensing issues are set to become the next battlefield in the US as legalization becomes more likely, reports CBD-Intel

With the majority of anti-cannabis users appearing to have accepted the eventual inevitability of some form of legalization, attention now turns to attempts to influence the shape of a possible future regime.

Traditional adversary industries like pharmaceuticals and alcohol have recently changed at least part of their lobbying strategy.

They are now trying to create limited licensing models that would benefit them as better funded companies by either dominating the market itself or limiting its impact on their core business interests.

John Kaweske, CEO of Tweedleaf, a Colorado medical and adult pharmacy chain, told CBD-Intel that outside government officials remain a threat to continued cannabis use.

By lobbying to limit licenses and introduce stricter licensing systems, companies that previously opposed cannabis are trying to create the kind of highly regulated, constrained market conditions for gamblers under which they already thrive. That is, they either beat back the competition by creating the conditions for artificially high prices, or they create a market into which they can enter themselves with considerable financial and experiential advantages.

“The concern of Special Interests is that they try to gain oligopoly-like advantages,” said Kaweske. “States with a restricted licensing model are simply un-American and violate free market principles.

“If the government creates a system of limited licenses and only issues those licenses to a small group of people, how does the American dream come true?”

Aside from concerns about allowing more people – especially those most disadvantaged by the decades-long war on drugs – to enjoy a slice of the lucrative cannabis pie, restricted licensing also hurts consumers directly as it leads to higher prices.

“In limited license states, the cost of cannabis is literally double what our consumers here in Colorado pay for the same product,” added Kaweske. “The consumer pays the price because of this restrictive market.”

But some of the larger cannabis companies can also benefit from limited licensing. This has created a messy situation with sometimes weird bedfellows.

For example, the Michigan Cannabis Manufacturers Association (MCMA), which represents some of the largest cannabis companies in Michigan, is campaigning for stricter regulations on medical cannabis caregivers and possibly more restrictions on home growing.

In essence, the MCMA wants to get as many sales as possible through licensed pharmacies for the benefit of its members.

However, current regulations allow medical cannabis keepers to support up to five patients, which can include growing as well as sourcing supplies from outside the pharmacy system.

This could mean growing up to 12 cannabis plants or purchasing up to 2.5 oz of product for the five patients, which could be combined with personal growing allowances if the caregiver is themselves registered as a medical cannabis patient to grow up to 72 plants.

The Michigan Medical Marijuana Association (MMMA) estimates that there are more than 36,000 registered nurses who could potentially care for a significant portion of the state’s 267,000 medical cannabis patients, according to the MMMA, removing them from the state’s licensed medical cannabis market, which is estimated to be around Estimated $ 1 billion.

The motivation for the companies that make up the MCMA to work to limit potential routes out of the market is obvious. MCMA members say they are concerned about the impact unregulated, unchecked and untaxed medical cannabis could have on consumers and government programs that rely on money.

But there have been calls from cannabis activists to boycott brands associated with membership of the trade group, including Fluresh, Two Joints, Jolly Edibles, North, Short’s Brewing, Petra, Wana, Sherbinski’s, Kiva Confections, DNA Genetics, Clout King , Chief Solventless and Crown Jewels.

Rick Thompson, owner of Michigan Cannabis Business Development Group, called any changes “unnecessary” and referred to the story of MCMA’s executive director Steve Linder.

“You have to acknowledge that Linder has been a real problem for the cannabis industry for years,” Thompson told the local media. “The consistent message from him and the MCMA was to put all cannabis sales under regulation.

“They want more sales to go through their stores. They advocate fundamentally changing the way nurses work to the extent that most of us believe that the program will be fundamentally changed and inoperable. “

The MCMA move puts them on the same side as pharmaceutical organizations that previously urged Michigan lawmakers to restrict nurse activity.

Similar activity can be seen on the recreational cannabis side.

A major problem for companies in states that allow alcohol and cannabis use on the same site is getting cities and other local jurisdictions to rewrite land use policies so that cannabis is visible. There’s also a problem with rewriting the zone restrictions so cannabis businesses can open in more desirable locations, according to House Caviar, a Los Angeles-based event planning company.

This has traditionally been opposed by the alcohol industry, which fears lost sales of cannabis in co-licensed locations, Antoinette Vu, co-founder of House Caviar, told CBD-Intel.

But local jurisdictions often prioritize tackling homelessness and unemployment in changes in land use policies – two social problems often linked to the war on drugs through convictions and other means.

This makes it easy for lobbyists to push other issues with public support and keep cannabis-related changes on the agenda, Vu added.

Ironically, many cannabis companies dealing with social issues such as homelessness and unemployment due to drug convictions could re-lobby on the same side of issues as those seeking to restrict cannabis licensing.

And the same shared loyalties can be seen at the federal level. Members of Congress have proposed several bills related to the legalization of cannabis, including:

• the highly progressive Cannabis Administration and Opportunity Act, which would remove cannabis from the controlled substances list
• the Moderately Progressive Marijuana Opportunity Reinvestment and Expungement (MORE) Act, a more progressive edition than the version passed by the House of Representatives last year
• the Common Sense Cannabis Reform For Veterans, Small Business, and Medical Professionals Act, which would replace the reinvestment and opportunity elements of the MORE Act with legalizing interstate cannabis trade, medical cannabis research, and providing access for military veterans.

Again, issues of social justice and opportunity lead to shared loyalties, with some in the industry advocating any kind of incremental change to slowly bring about a new federal cannabis regime. Others take the position of Democratic Senator Cory Booker of New Jersey and are less opposed to action aimed at promoting broader legislation.

Some companies outside of the cannabis sector, such as Amazon, have publicly supported measures such as the MORE Act. Amazon declined to tell CBD-Intel whether it had backed its public support with money from lobbyists.

Similarly, Big Alcohol and Big Tobacco in particular are silent about their lobbying activities alongside general inclusive propaganda. However, there is a feeling that such companies would be at a disadvantage in terms of either dominance or the safeguarding of their core interests if the focus were on accessing and improving under-represented communities and limited businesses.

As a result, the general activity of traditional cannabis opponents remains worrying – not least because of their much larger war coffers. It has been estimated that cannabis lobbyists spent only $ 4 million on political advocacy last year, compared to the $ 60 million alcohol and tobacco groups contributed to all issues.

A survey of its members conducted by the national cannabis advocacy group NORML found that a majority of consumers do not support alcohol and tobacco companies that influence cannabis policy. A total of 77.6% said it was a problem, just under 47% said it was a big problem and the rest said it was only a problem “when companies advocate policies that address consumer issues There is a conflict ”.

“We have already seen the impact of these corporate interests,” said Erik Altieri, NORML’s Executive Director. “In some cases, many of these people have opposed consumer-friendly legalization regulations, such as the right for adults to grow marijuana in the privacy of their home.

“These business units have also pushed for statewide limits on the number of licensed cannabis producers and dealers to keep prices high and artificially limited – and keep the economic benefits of legalization largely out of the reach of the average American,” especially People of Color. “

What that means: NORML’s concerns are understandable. It is interesting to note that in terms of legalized territory and acceptance, cannabis is growing, it is also becoming more corporate.

Natty Suits and Flash Cars are rapidly replacing RVs and patchouli, potentially bringing the industry into greater conflict with itself – especially as parts of them realize they have more in common with the lobbying positions of former external opponents.

Vigorous prohibitionists are increasingly being sidelined. Even longtime traditional lobbyist opponents like Safe Approaches to Marijuana have changed course from advocating a ban to advocating restrictions while continuing to warn of potential dangers.

With increasing pressure to change at the federal level and in the remaining prohibition states, it will be interesting to see where the money is going and how issues such as licensing and land use develop.

What is clear for now is that there is unlikely to be a clear divide between those within the sector and those outside the sector.

–

CBD-Intel (www.CBD-Intel.com) provides impartial, independent and world-class market and regulatory research, law enforcement and quantitative data for the cannabidiol (CBD) sector.

We offer our clients the tools to navigate this fast-moving sector, adjust their business strategy, optimize resources and make informed decisions. In addition, we offer tailor-made research and advice support.

As people discover the benefits of the non-psychoactive cannabinoid cannabidiol (CBD), they wonder if it could benefit their animal companions as well. However, human and animal bodies process cannabinoids differently [3]. So what do we really know about the paw print of CBD in the cannabinoid world?

Important points

• If you give your dog a larger single dose of CBD, the effects won’t get any stronger [3].
• Dogs get more CBD from an oral dose than humans [3].
• Dogs and cats require different dosages of CBD [1].
• Traces of THC in CBD products can have negative effects on pets [4].
• Always speak to your veterinarian before giving CBD to your pet.

Research on CBD for dogs was published back in 1988 [3]. This study tested pure CBD given intravenously or orally to dogs. The researchers found that the effects of CBD in dogs were not dose-dependent. This means that if you give the dog more CBD, you won’t necessarily get more potency. They also found that oral bioavailability (the amount of active CBD in the body) was 13% to 19%, which is better absorption than humans.

People give CBD to dogs and cats for disorders related to anxiety, seizures, cancer, and pain [1]. A 2019 research paper explains that cats have a higher rate of oral absorption than dogs. Overall, CBD appears to be well tolerated by adult dogs, but less is known about CBD for cats. For this reason, it is extremely important to speak to your veterinarian before giving CBD products to your dog or cat. Only they can advise you on the correct dosage for your pet. Since CBD can have side effects and drug interactions, they can also tell you whether it is safe for your pet to take CBD.

Now that we’ve talked about CBD dosage for dogs and cats and how they absorb CBD, let’s consider whether CBD is actually beneficial for pets. In a 2018 study, dogs with osteoarthritis were given CBD oil and their pain level was assessed after four weeks [2]. Overall, the dog’s pain level appeared to be decreasing and its activity level improved. The dogs were also allowed to receive NSAIDs, fish oil, and / or glucosamine / chondroitin sulfate. This study is far from final, but it does give us the insight that when combined with standard veterinary treatment, CBD can improve dog health and reduce pain associated with osteoarthritis.

Finally, choosing the right CBD product for your pet is important. Your veterinarian is the most qualified person to make a recommendation. Much care needs to be taken as even traces of the psychoactive tetrahydrocannabinol (THC) can cause side effects to your dog. While most of the CBD side effects are mild, people can also tolerate THC better. A 2020 study observed that dogs given CBD containing traces of THC experienced side effects such as lethargy, hypothermia, and ataxia (loss of complete control over body movements). [4]. So watch out for such side effects, opt for CBD isolate for pets and always speak to your veterinarian!

References

1- Deabold KA, Schwark WS, Wolf L, Wakshlag JJ. Single-dose pharmacokinetics and preliminary safety assessment of the use of high-CBD hemp nutraceutical in healthy dogs and cats. Animals. 2019; 9 (10): 832. doi: 10.3390 / ani9100832

2- Gamble LJ, Boesch JM, Frye CW et al. Pharmacokinetics, safety, and clinical efficacy of cannabidiol treatment in osteoarthritic dogs. Limits in Veterinary Science. 2018; 5. doi: 10.3389 / fvets.2018.00165 Retrieved August 12, 2021. https://internal-journal.frontiersin.org/articles/10.3389/fvets.2018.00165/full#h3

3- Samara E., M. Bialer, R. Mechoulam. Pharmacokinetics of cannabidiol in dogs. Drug metabolism and disposition. 1988; 16 (3): 469-472. Retrieved August 12, 2021. https://dmd.aspetjournals.org/content/16/3/469.short

4- Vaughn D, Kulpa J, Paulionis L. Preliminary study of the safety of escalating cannabinoid doses in healthy dogs. Limits in Veterinary Science. 2020; 7. doi: 10.3389 / fvets.2020.00051, accessed August 12, 2021. https://www.frontiersin.org/articles/10.3389/fvets.2020.00051/full

picture: https://www.pexels.com/photo/man-person-love-people-6235648/ by Tima Miroshnichenko from Pexels.com

Hemp and cannabis strains have striking similarities. However, they differ in the amount of THC that is in each one.

THC has psychoactive or mind altering abilities. As a result, it is classified in Appendix 1 and is considered illegal under federal law. Since hemp only contains traces of THC, it does not fall into this category. If anything, it was fully legalized at the federal level with the passage of the Agricultural Act 2018.

The percentage of THC in hemp is his make or break; cross the 0.3% threshold and officially you are dealing with marijuana. Depending on your state laws, you could run into big problems!

When you get the exact amount of THC in a sample, the rubber hits the road. Most laboratories are not equipped with the proper techniques to do this effectively. This difference in quantification and testing methods makes it difficult to standardize in the industry. This is an area that needs to be investigated.

The National Institute of Standards and Technology (NIST) just released the results of a study designed to help laboratories get accurate THC measurements in samples for informed decision-making. This goes hand in hand with their quality assurance program under the CannaQAP brand. The results that have been anonymized were published on the NIST website in July. The reason for maintaining anonymity was to encourage laboratories to participate without worrying about “failing” or “passing” the test.

Hemp samples were prepared with exact amounts of THC, CBD, and other compounds and sent to various laboratories for testing. One hundred and sixteen laboratories participated, including commercial laboratories performing cannabis testing and academic chemical testing laboratories. Almost 83 percent of the participating laboratories sent data to the NIST. The labs measured various cannabinoids (and pollutants) and sent the results to the NIST lab for comparison.

Although the results fluctuated significantly, the researchers said this was normal and to be expected:

“The entire industry does quite well with the target values.”

With this study, NIST hopes to create a learning opportunity for cannabis testing laboratories and help standardize testing methods in the industry. NIST will also use the results to determine the methods and practices that will work best.

Finally, NIST hopes to create a reference material for hemp that will serve as an industry guide.

Image source

https://cbdhealthandwellness.net/2021/08/02/does-cbd-athletic-tape-work/

Cannabidiol (CBD) topicals are nothing new, but with summer in full swing they are becoming very popular as part of a comprehensive skin care regimen, especially when it comes to protecting the skin from the potentially harmful UV rays. It can be dangerous to leave your skin unprotected when you are in the sun for a long time, especially for people with particularly sensitive skin.

CBD has been linked to a seemingly endless list of benefits, and skin protection is just one of them.

The anti-inflammatory properties of CBD for better skin health

For starters, CBD has anti-inflammatory properties that can help keep skin from becoming inflamed from the sun’s rays. [1] And when combined with other active ingredients common in sunscreen products, like zinc oxide, CBD can work wonders to keep skin healthy, hydrated, and protected from the sun.

In fact, it’s the anti-inflammatory properties of CBD that have linked the cannabinoid to a host of health benefits, including promoting better skin. [2] The interaction of CBD with the endocannabinoid system in the body allows it to act at the cellular level to reduce inflammation that is not only at the core of sunburns after a day outdoors, but also eczema, acne, and other skin conditions that cause flare-ups cause due to an underlying inflammation.

CBD skin care products are also often fortified with essential oils to add another protective layer to the skin while adding an aromatic component to the product.

Even in summer, skin care should focus on moisturizing care. Hence, moisturizers should be applied regularly to avoid dry skin, which tends to accompany a day in the sun. Applying a moisturizer under the sunscreen can keep the skin well hydrated while the sunscreen protects against UV rays.

There are more and more moisturizers out there that are already fortified with CBD. However, if you already have a favorite that you use regularly, adding a few drops of CBD oil can help boost the skin’s moisturizing and moisturizing properties.

Lip protection with CBD

In addition to protecting the skin on the face and body, it is important not to ignore the lips. There are several lip products that have both moisturizing properties and added SPF protection from the sun.

But many more are being launched that are fortified with CBD oil to help nourish the lips and prevent problems like dryness, cracking, and more serious sun-related issues. Again, CBD lip products tend to contain other ingredients to maximize protection and hydration, including beeswax and essential oils.

Enjoy the summer safely with high quality CBD infused skin care products.

Image source: Igor Link from Pixabay

References:

1. Nagarkatti, P., et al., “Cannabinoids as novel anti-inflammatory drugs“Future Med Chem., October 2009, 1 (7): 1333-1349.

2. Baswan, SM, et al. “Cannabidiol (CBD) has therapeutic potential for skin health and skin conditions“, Clin Cosmet Investig Dermatol., 2020, 13: 927-942.

Cannabidiol (CBD) is a cannabinoid molecule derived from cannabis that has gained a reputation for relieving symptoms of inflammation and muscle spasticity, and reducing symptoms of anxiety and depression. This has led researchers to believe that CBD could be beneficial in multiple sclerosis (MS). An estimated 2.3 million people worldwide have multiple sclerosis [2]. This central nervous system disorder causes demyelination of neurons, leading to symptoms such as pain, muscle tightness, fatigue, inflammation, and depression.

In rodent models and some human studies, CBD has shown benefits in the symptoms of MS. Its effects, such as regulating T-cell activity and inflammatory factors, are believed to be particularly beneficial in improving MS symptoms such as pain, inflammation, and muscle spasms [1]. CBD has also shown the potential to relieve mood-related symptoms, such as anxiety and depression, that many people with MS suffer from [2].

CBD and another cannabinoid tetrahydrocannabinol (THC) for MS have been recommended in a CBD: THC ratio of 1: 1 or higher [2]. The 1: 1 preparation called “Nabiximols” is one of the most commonly used in scientific studies on CBD for MS [1]. The dosage recommendation for non-THC CBD in MS has not yet been fully understood and remains a major topic for clinical recommendation of CBD in MS.

CBD acts on the body through the endocannabinoid system and its receptors. This body system regulates the functions of the immune system and the nervous system. CBD can work in many ways. One of the most important mechanisms of action in MS is to suppress inflammatory factors and to modulate the response of the immune and nervous systems. By reducing the release of inflammatory factors, a person can experience less pain and better mobility.

Why Do Doctors Not Recommend CBD for Multiple Sclerosis? The answer is mainly that there are still no major human clinical trials. Many doctors have started recommending medicinal cannabis or nabiximol to their patients. However, without clinical study data and formal dosage recommendations, some doctors cannot yet recommend CBD for MS. Researchers suggest that using CBD in MS could eliminate or reduce the use of riskier drugs like opioids [2]. So there is much hope that CBD will become a more accepted option for MS patients.

References

1- Furgiuele A, Cosentino M, Ferrari M, Marino F. Immunomodulatory potential of cannabidiol in multiple sclerosis: a systematic review. Journal of Neuroimmune Pharmacology. 2021; 16 (2): 251-269. doi: 10.1007 / s11481-021-09982-7 Retrieved June 20, 2021 from https://link.springer.com/article/10.1007/s11481-021-09982-7

2- Rudroff T, Sosnoff J. Cannabidiol for improving mobility in people with multiple sclerosis. Limits in Neurology. 2018; 9. doi: 10.3389 / fneur.2018.00183 Retrieved June 20, 2021 from https://www.frontiersin.org/articles/10.3389/fneur.2018.00183/full

Picture: https://www.pexels.com/photo/photo-of-man-sitting-on-a-ct-scanner-7088488/ from MART PRODUCTION from Pexels

Anyone who has experienced severe sunburn knows that the healing process can be complicated and uncomfortable. You can even end up in the hospital depending on the severity of your sunburn. Knowing how to treat sunburn can save you a lot of discomfort and pain.

This is why people are turning to CBD (cannabidiol). Getting sunburned is not the same as just getting burned with something hot. The sun emits rays that damage the skin and trigger an immune response. CBD could be useful as research shows it can modulate the immune system (1). Your skin is full of cannabinoid receptors, which could explain how CBD lotion could help treat sunburn.

“Since the ECS has an important regulatory role in the skin, it is plausible that treatment with topical cannabinoids could be effective for certain conditions or skin health in general,” wrote a team of researchers involved in a 2020 study (2).

“There is evidence that topical application of cannabinoids, and especially CBD, may be a viable route of administration for certain diseases.”

It is not certain that sunburns are among the conditions treated with CBD. But the evidence is promising, and many in the industry believe that CBD-based skin treatments will become common.

In a separate 2020 study published in Molecules, a team of researchers wrote that although government regulations continue to hinder cannabinoid studies, “interest in the area is growing as more evidence of the effectiveness of these substances and cannabinoid uses.” The treatment of skin diseases could become conventional in the future. (3). “

If you want to try CBD after sunburn, invest in a good quality lotion or oil. With its medical benefits still being researched, CBD is not yet a well-regulated product. This means that customers need to take extra steps to ensure that they are buying well-made CBD.

Image source: Wikipedia

References:

1- Tanasescu, Radu, and Cris S. Constantinescu. “Cannabinoids and the Immune System: An Overview.” Immunobiology Flight. 215.8 (2010): 588-97. doi: 10.1016 / j.imbio.2009.12.005

2- Baswan, SudhirM, et al. “Therapeutic potential of cannabidiol (CBD) for skin health and skin diseases.” Clinical, cosmetic and trial dermatology vol. 13 927-942. Dec. 8, 2020, doi: 10.2147 / CCID.S286411

3- Scheu, Cristian et al. “Cannabinoids in the pathophysiology of skin inflammation.” Molecules (Basel, Switzerland) vol. 25.3 652. 4 Feb. 2020, doi: 10.3390 / Molecules25030652

With so many medicinal benefits, cannabidiol (CBD) is added to everything from water to clothing to pillows. Although the science behind the benefits of CBD is solid, the science that it is effective when added to things like clothing makes these types of CBD uses questionable. One method of CBD application is being marketed to athletes, and that is a CBD-infused sports tape. Let’s take a look at the facts.

As an athlete and certified personal trainer, I am very familiar with athletic tape, also known as kinesiology tape. Sporttape is known to improve blood circulation, stimulate the lymphatic system, and support muscles with the aim of improving recovery from injury or preventing injury. It relieves pain by reducing inflammation and by keeping muscle strain or sore muscles in place when active. For these reasons, it is very common in locker rooms of all sports.

CBD is also known to relieve pain and reduce inflammation, which makes it popular with athletes as well. It would make sense that the combination of CBD with sports tape should result in a pain relieving, anti-inflammatory combination. However, there is currently no scientific research to support the effectiveness of CBD when infused with sports tape. Without any definitive proof, I’m cautious in suggesting that CBD sports tape works, but there are still several different brands on the market that sell some type of CBD sports tape. Some of them even have high ratings from consumers, but the relief they feel could only come from the benefits of using sports tape itself, and not necessarily from CBD.

That being said, I’ve never tried CBD sports tape myself, but as a personal trainer advising clients, it’s all about the science of athletic performance and recovery. Until there is definitive research specifically on the effectiveness of CBD administered through sports tape, I cannot say for sure that it will work. I recommend trying sports tape, and if you go for one with CBD, that’s perfectly fine.

With so many medicinal benefits, cannabidiol (CBD) is added to everything from water to clothing to pillows. Although the science behind the benefits of CBD is solid, the science that it is effective when added to things like clothing makes these types of CBD uses questionable. One method of CBD application is being marketed to athletes, and that is a CBD-infused sports tape. Let’s take a look at the facts.

As an athlete and certified personal trainer, I am very familiar with athletic tape, also known as kinesiology tape. Sporttape is known to improve blood circulation, stimulate the lymphatic system, and support muscles with the aim of improving recovery from injury or preventing injury. It relieves pain by reducing inflammation and by keeping muscle strain or sore muscles in place when active. For these reasons, it is very common in locker rooms of all sports.

CBD is also known to relieve pain and reduce inflammation, which makes it popular with athletes as well. It would make sense that the combination of CBD with sports tape should result in a pain relieving, anti-inflammatory combination. However, there is currently no scientific research to support the effectiveness of CBD when infused with sports tape. Without any definitive proof, I’m cautious in suggesting that CBD sports tape works, but there are still several different brands on the market that sell some type of CBD sports tape. Some of them even have high ratings from consumers, but the relief they feel could only come from the benefits of using sports tape itself, and not necessarily from CBD.

That being said, I’ve never tried CBD sports tape myself, but as a personal trainer advising clients, it’s all about the science of athletic performance and recovery. Until there is definitive research specifically on the effectiveness of CBD administered through sports tape, I cannot say for sure that it will work. I recommend trying sports tape, and if you go for one with CBD, that’s perfectly fine.